We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$2.83B
AUM Growth
-$51.8M
Cap. Flow
-$96.1M
Cap. Flow %
-3.4%
Top 10 Hldgs %
16%
Holding
1,400
New
374
Increased
259
Reduced
316
Closed
442

Sector Composition

Rank Sector Weight
1 Healthcare 19.64%
2 Financials 15.46%
3 Consumer Discretionary 11.37%
4 Technology 10.29%
5 Energy 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNP icon
201
CenterPoint Energy
CNP
$28.3B
$3.5M 0.12%
122,459
+110,531
+927% +$3.3M
SILK
202
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$3.48M 0.12%
+71,900
New +$3.06M
NEE icon
203
NextEra Energy
NEE
$185B
$3.44M 0.12%
67,200
+22,400
+50% +$1.1M
PII icon
204
Polaris
PII
$3.83B
$3.42M 0.12%
+37,500
New +$3.41M
CBLK
205
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$3.4M 0.12%
+203,200
New +$3.12M
LVS icon
206
Las Vegas Sands
LVS
$31.4B
$3.31M 0.12%
56,000
-109,700
-66% -$6.8M
EPZM
207
DELISTED
Epizyme, Inc
EPZM
$3.27M 0.12%
260,900
-155,700
-37% -$2M
AG icon
208
First Majestic Silver
AG
$7.52B
$3.27M 0.12%
+413,400
New +$2.61M
EMN icon
209
Eastman Chemical
EMN
$7.69B
$3.23M 0.11%
41,454
+25,454
+159% +$1.93M
GNLN icon
210
Greenlane Holdings
GNLN
$1.06M
0
LNC icon
211
Lincoln National
LNC
$7.92B
$3.22M 0.11%
49,924
+5,562
+13% +$355K
MTCH icon
212
Match Group
MTCH
$9.19B
$3.2M 0.11%
47,600
+37,200
+358% +$2.43M
NBIX icon
213
Neurocrine Biosciences
NBIX
$18.2B
$3.2M 0.11%
37,900
-16,400
-30% -$1.35M
MLCO icon
214
Melco Resorts & Entertainment
MLCO
$2.21B
$3.2M 0.11%
147,159
+56,260
+62% +$1.28M
JD icon
215
JD.com
JD
$43.5B
$3.19M 0.11%
+105,300
New +$3.03M
KEY icon
216
KeyCorp
KEY
$23.8B
$3.15M 0.11%
+177,400
New +$3M
ATI icon
217
ATI
ATI
$24.3B
$3.11M 0.11%
123,400
+103,600
+523% +$2.53M
INTU icon
218
Intuit
INTU
$91.1B
$3.11M 0.11%
11,887
+10,887
+1,089% +$2.77M
MCO icon
219
Moody's
MCO
$83.7B
$3.1M 0.11%
+15,876
New +$3.01M
EQIX icon
220
Equinix
EQIX
$99.4B
$3.08M 0.11%
6,100
-200
-3% -$95.9K
BLFS icon
221
BioLife Solutions
BLFS
$1.54B
$3.07M 0.11%
181,300
-93,900
-34% -$1.64M
COF icon
222
Capital One
COF
$128B
$3.06M 0.11%
33,770
+8,452
+33% +$756K
DLTR icon
223
Dollar Tree
DLTR
$24.8B
$3.05M 0.11%
28,400
-74,127
-72% -$7.8M
VRTX icon
224
Vertex Pharmaceuticals
VRTX
$123B
$3.04M 0.11%
16,600
-2,800
-14% -$489K
PCRX icon
225
Pacira BioSciences
PCRX
$1.04B
$3.03M 0.11%
69,600
+10,200
+17% +$433K

Similar funds

Schonfeld Strategic Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Schonfeld Strategic Advisors held 1,400 positions worth $2.83B, down 1.8% from $2.88B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Schonfeld Strategic Advisors withdrew a net $96.1M in Q2 2019, closing 442 positions and reducing 316 holdings. Its most notable exit was Conagra Brands, an estimated $43.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Schonfeld Strategic Advisors opened a new position in Equitrans Midstream Corporation Common Stock worth $42.1M.

  • Schonfeld Strategic Advisors's largest Q2 2019 buy was Equitrans Midstream Corporation Common Stock: 2,136,064 shares worth $42.1M.
  • Schonfeld Strategic Advisors added most to NRG Energy in Q2 2019, an estimated $61.4M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2019 reduction was Target, cutting an estimated $30.5M.
  • Schonfeld Strategic Advisors fully exited Conagra Brands in Q2 2019, selling an estimated $43.5M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 16% of its $2.83B portfolio in Q2 2019.
  • Schonfeld Strategic Advisors opened 374 new positions and closed 442 in Q2 2019.
  • Schonfeld Strategic Advisors's portfolio value fell 1.8% quarter-over-quarter to $2.83B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.